Header Logo

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy.

Bispecific antibodies targeting CTLA-4: game-changer troopers in cancer immunotherapy. Front Immunol. 2023; 14:1155778.

View in: PubMed